These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
450 related articles for article (PubMed ID: 29141885)
21. Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease. Ma HQ; Yu TT; Zhao XJ; Zhang Y; Zhang HJ World J Gastroenterol; 2018 Apr; 24(13):1464-1477. PubMed ID: 29632427 [TBL] [Abstract][Full Text] [Related]
22. Dysbiosis in Crohn's disease - Joint action of stochastic injuries and focal inflammation in the gut. Buttó LF; Haller D Gut Microbes; 2017 Jan; 8(1):53-58. PubMed ID: 28102757 [TBL] [Abstract][Full Text] [Related]
23. Propionate catabolism by CD-associated adherent-invasive Agus A; Richard D; Faïs T; Vazeille E; Chervy M; Bonnin V; Dalmasso G; Denizot J; Billard E; Bonnet R; Buisson A; Barnich N; Delmas J Gut Microbes; 2021; 13(1):1-18. PubMed ID: 33769191 [TBL] [Abstract][Full Text] [Related]
24. Host and microbiota interactions are critical for development of murine Crohn's-like ileitis. Roulis M; Bongers G; Armaka M; Salviano T; He Z; Singh A; Seidler U; Becker C; Demengeot J; Furtado GC; Lira SA; Kollias G Mucosal Immunol; 2016 May; 9(3):787-97. PubMed ID: 26487367 [TBL] [Abstract][Full Text] [Related]
25. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease. Sun MF; Shen YQ Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121 [TBL] [Abstract][Full Text] [Related]
26. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease. Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876 [TBL] [Abstract][Full Text] [Related]
30. The Crohn's disease polymorphism, Lavoie S; Conway KL; Lassen KG; Jijon HB; Pan H; Chun E; Michaud M; Lang JK; Gallini Comeau CA; Dreyfuss JM; Glickman JN; Vlamakis H; Ananthakrishnan A; Kostic A; Garrett WS; Xavier RJ Elife; 2019 Jan; 8():. PubMed ID: 30666959 [TBL] [Abstract][Full Text] [Related]
31. A Distinct Gut Microbiota Exists Within Crohn's Disease-Related Perianal Fistulae. Haac BE; Palmateer NC; Seaton ME; VanYPeren R; Fraser CM; Bafford AC J Surg Res; 2019 Oct; 242():118-128. PubMed ID: 31075656 [TBL] [Abstract][Full Text] [Related]
32. Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease. He C; Wang H; Liao WD; Peng C; Shu X; Zhu X; Zhu ZH World J Gastroenterol; 2019 May; 25(18):2204-2216. PubMed ID: 31143071 [TBL] [Abstract][Full Text] [Related]
33. Implications of gut microbiota dysbiosis and metabolic changes in prion disease. Yang D; Zhao D; Shah SZA; Wu W; Lai M; Zhang X; Li J; Guan Z; Zhao H; Li W; Gao H; Zhou X; Yang L Neurobiol Dis; 2020 Feb; 135():104704. PubMed ID: 31837420 [TBL] [Abstract][Full Text] [Related]
34. NOD2 Influences Trajectories of Intestinal Microbiota Recovery After Antibiotic Perturbation. Moltzau Anderson J; Lipinski S; Sommer F; Pan WH; Boulard O; Rehman A; Falk-Paulsen M; Stengel ST; Aden K; Häsler R; Bharti R; Künzel S; Baines JF; Chamaillard M; Rosenstiel P Cell Mol Gastroenterol Hepatol; 2020; 10(2):365-389. PubMed ID: 32289499 [TBL] [Abstract][Full Text] [Related]
35. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease. Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154 [TBL] [Abstract][Full Text] [Related]
36. The Role of Gut Microbiota in Inflammatory Bowel Disease-Current State of the Art. Askari H; Shojaei-Zarghani S; Raeis-Abdollahi E; Jahromi HK; Abdullahi PR; Daliri K; Tajbakhsh A; Rahmati L; Safarpour AR Mini Rev Med Chem; 2023; 23(13):1376-1389. PubMed ID: 36111766 [TBL] [Abstract][Full Text] [Related]
37. Gut bacteriome in inflammatory bowel disease: An update on recent advances. Bajaj A; Markandey M; Kedia S; Ahuja V Indian J Gastroenterol; 2024 Feb; 43(1):103-111. PubMed ID: 38374283 [TBL] [Abstract][Full Text] [Related]
38. Overrepresentation of Enterobacteriaceae and Khorsand B; Asadzadeh Aghdaei H; Nazemalhosseini-Mojarad E; Nadalian B; Nadalian B; Houri H Front Cell Infect Microbiol; 2022; 12():1015890. PubMed ID: 36268225 [TBL] [Abstract][Full Text] [Related]
39. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis. Yu LC J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188 [TBL] [Abstract][Full Text] [Related]
40. Dynamics of the human gut microbiome in inflammatory bowel disease. Halfvarson J; Brislawn CJ; Lamendella R; Vázquez-Baeza Y; Walters WA; Bramer LM; D'Amato M; Bonfiglio F; McDonald D; Gonzalez A; McClure EE; Dunklebarger MF; Knight R; Jansson JK Nat Microbiol; 2017 Feb; 2():17004. PubMed ID: 28191884 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]